🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Pre-incisional Infiltration With Ropivacaine Plus Diprospan for Relieving Postoperative Pain After Laparoscopic Surgery
NCT07626463Laparoscopic Surgery, Laparoscopic Appendectomy, Laparoscopic Cholecystectomy, Laparoscopic Hernia Repair Surgery
Beijing Tiantan Hospital
Not applicable
150
Beijing
2026-05-30
Not yet open
Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study)
NCT07601997STEMI - ST Elevation Myocardial Infarction
Myomed Technology (Shaoxing) Co., Ltd.
Not applicable
20
Xi'an
2026-05-30
Not yet open
Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI
NCT07551414NSCLC (Non-small Cell Lung Carcinoma), Leptomeningeal Metastasis, EGFR-TKI Sensitizing Mutation, Zorifertinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
38
Beijing
2026-05-30
Not yet open
Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer
NCT07537946Hepatocellular Carcinoma (HCC), Metastases
Tongji Hospital
Phase 3
400
Wuhan
2026-05-30
Not yet open
Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma
NCT07601607Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Sun Yat-sen University
Phase 1/2
51
Guangzhou
2026-05-30
Not yet open
Real-World Data Linkage Research Platform
NCT07635355Chronic Diseases, Sub-optimal Health
Beijing Friendship Hospital
Observational
300,000
Beijing
2026-05-30
Recruiting
Video-guided Versus Conventional Right-sided Double-Lumen Tubes for One-Lung Ventilation in Thoracoscopic Surgery
NCT07362797Thoracoscopic Surgery, Double Lumen Tube Intubation, One-Lung Ventilation
Diansan Su
Not applicable
566
Hangzhou, Jiaxing
2026-05-30
Not yet open
JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC
NCT07582822Advanced Solid Tumor
Biotech Pharmaceutical Co., Ltd.
Phase 1
60
Chongqing, Zhengzhou, Changsha, Nanjing, Xi'an, Shanghai, Taiyuan, Chengdu
2026-05-30
Not yet open
FAK Inhibitor in Patients With Advanced Solid Tumors
NCT07596381Advanced Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1
75
Hangzhou
2026-05-30
Recruiting
Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP
NCT07493109Diffuse Large B-Cell Lymphoma (DLBCL)
Ou Bai, MD/PHD
Phase 3
200
Changchun
2026-05-30
Not yet open
ATRA for Management of Primary ITP
NCT07597395Immune Thrombocytopenia
Peking University People's Hospital
Phase 3
192
Beijing
2026-05-30
Not yet open
A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer
NCT07615907Gastric Cancer (GC)
Jinling Hospital, China
Not applicable
20
Nanjing
2026-05-30
Not yet open
Efficacy and Safety of Transcranial Temporal Interference Stimulation for Depression
NCT07612501Major Depressive Disorder (MDD)
Yonggui Yuan
Not applicable
60
Nanjing
2026-05-30
Recruiting
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
NCT07622667Malignant Tumors
Nanfang Hospital, Southern Medical University
Observational
500
Guangzhou
2026-05-29
Not yet open
SLN12140 in Adult Participants With IgA Nephropathy in China
NCT07553494IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc.
Phase 2
48
Beijing
2026-05-29
Recruiting
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
NCT07528027Hypertension With Overweight or Obesity
Shandong Suncadia Medicine Co., Ltd.
Phase 3
648
Beijing, Harbin
2026-05-29
Active, closed
Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation
NCT07687433Rectal Cancer Patients
Harbin Medical University
Phase 2
43
Harbin
2026-05-29
Not yet open
Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma
NCT07615283Relapsed or Refractory Peripheral T Cell Lymphoma, NKTCL
Sun Yat-sen University
Phase 1/2
40
Guangzhou
2026-05-29
Not yet open
A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors
NCT07583316Lung Cancer (Locally Advanced or Metastatic), Esophagus Cancer, Head and Neck Cancer, Hepatocellular Carcinoma (HCC)
Corregene Biotechnology Co., Ltd
Phase 1
192
Beijing
2026-05-29
Recruiting
Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT07750951MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma
Xijing Hospital
Phase 2
34
Xi'an
2026-05-29
Active, closed
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07483268CRSWNP
Chengdu Kangnuoxing Biopharma,Inc.
Observational
600
Beijing
2026-05-29
Active, closed
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion
NCT07466225Hepatocellular Carcinoma (HCC)
Peking University
Observational
150
Beijing
2026-05-29
Recruiting
Unipolar Radiofrequency Treatment Combined With SkinCeuticals A.G.E. Ultra Cream for Facial Rejuvenation
NCT07753564Facial Rejuvenation
Beijing Artemis Medical Beauty Clinic
Not applicable
50
Beijing
2026-05-29
Recruiting
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07574346Malignancies
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-29
Recruiting
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease
NCT07551492Atherosclerotic Cardiovascular Disease
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
9,262
Beijing
2026-05-29
By invitation
A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
NCT07633197Herpes
Changchun BCHT Biotechnology Co.
Phase 1
120
Zhengzhou
2026-05-28
Recruiting
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
NCT06993506HER2-negative Breast Cancer, Recurrence, Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Hefei, Beijing, Fuzhou, Xiamen, Shijiazhuang, Zhengzhou, Shiyan, Wuhan
2026-05-28
Recruiting
JS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07584135Gastric Adenocarcinoma
NingBo Junyan Hongshi Biosciences Co., Ltd
Phase 3
600
Guangzhou
2026-05-28
Recruiting
Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
NCT07744529Leptomeningeal Metastasis From Lung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
15
Hangzhou
2026-05-28
Recruiting
Growth and Health Efficacy of Novel Infant Formula : A Randomized Trial
NCT07534735Infant Growth
Biostime (Changsha) Nutrition Foods Limited
Not applicable
120
Shenzhen
2026-05-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07463521Ocular Myasthenia Gravis
UCB Biopharma SRL
Phase 3
120
Beijing, Chengdu, Nanchang, Suzhou
2026-05-27
Recruiting
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
NCT07459751Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
Shanghai Henlius Biotech
Phase 2/3
706
Beijing
2026-05-27
Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
NCT07477587Multiple Myeloma (MM)
Shanghai Henlius Biotech
Phase 1
258
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Meizhou
2026-05-27
Recruiting
Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
NCT07512583Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1/2
178
Beijing, Harbin, Tianjin
2026-05-27
Recruiting
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
NCT07550816Overweight,Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
60
Chengdu
2026-05-27
Recruiting
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
NCT07785934Drug Drug Interaction (DDI), Pharmacokinetics and Pharmacodynamics
The United Bio-Technology (Hengqin) Co., Ltd.
Phase 1
48
Hefei
2026-05-27
Active, closed
Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study
NCT07663071Rectal Cancer Patients
Harbin Medical University
Phase 2
44
Harbin
2026-05-27
Recruiting
Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay
NCT07369960Developmental Delay Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS), Global Developmental Delay, Language Disorders in Children
Xiangya Hospital of Central South University
Not applicable
50
Jishou
2026-05-27
By invitation
Disposable Intestinal Isolation and Protection Device for Patients With Rectal and Lower Sigmoid Colon Tumors Undergoing Laparoscopic AR/LAR Surgery
NCT07825129Disposable Intestinal Isolation and Protection Device
Beijing Friendship Hospital
Not applicable
140
Beijing
2026-05-27
Recruiting
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
NCT06527326Central Serous Chorioretinopathy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hanzhou
2026-05-27
Not yet open
Plasma Concentrations of Intraosseous Versus Intravenous Tranexamic Acid in Joint Arthroplasty
NCT07614087Osteoarthritis
Hua Luo
Phase 4
80
Linhai
2026-05-27
Not yet open
Stepwise vs Standard Anticoagulation for AF Patients Undergoing CIED Implantation (STEP-AF)
NCT07616414Non-valvular Atrial Fibrillation (NVAF), Thromboembolism, Cardiac Implantable Electronic Device, Perioperative Bleeding
Fu Wai Hospital, Beijing, China
Not applicable
424
Beijing
2026-05-26
Recruiting
Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
NCT07622771Rectal Cancers
Sun Yat-sen University
Phase 2
84
Guangzhou
2026-05-26
Recruiting
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
NCT07513441Parkinson Disease
H. Lundbeck A/S
Phase 1
10
Beijing, Shanghai Shi, Chengdu
2026-05-26
Recruiting
Exploration of Circular RNA in B-cell Hematologic Malignancies
NCT07774572Lymphoma, B-Cell Refractory
Ruijin Hospital
Phase 1
30
Shanghai
2026-05-26
Recruiting
HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
NCT07629778Atopic Dermatitis
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 1/2
156
Hangzhou
2026-05-26
Recruiting
A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function
NCT07540754Diabetes Mellitus, Weight Loss
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
24
Zhengzhou
2026-05-26
Recruiting
IASO-782 in Systemic Lupus Erythematosus
NCT07483346SLE - Systemic Lupus Erythematosus
Shanghai IASO Biotechnology Co., Ltd
Phase 1
20
Hangzhou, Huzhou, Jiaxing
2026-05-26
Recruiting
Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC.
NCT07279935Non-small Cell Lung Cancer
AstraZeneca
Phase 4
100
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan
2026-05-26
Recruiting
A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
NCT07607054Locally Advanced or Metastatic Solid Tumors
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1
50
Guangzhou
2026-05-26
Recruiting
A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
NCT07579741HIV Infections
Jecho Biopharmaceuticals Co., Ltd.
Phase 1/2
30
Beijing
2026-05-26
Recruiting
Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors
NCT07744074Carbon Ion Radiotheray
Ji Yongling
Not applicable
12
Hangzhou
2026-05-26
Recruiting
Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma
NCT07727642AIDS-related Lymphoma, HIV Infection
Shanghai Public Health Clinical Center
Not applicable
60
Shanghai
2026-05-26
Recruiting
Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)
NCT07668271Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd
Phase 4
720
Zhangping
2026-05-26
Recruiting
Brain Network Characteristics of Pain Patients Based on Magnetoencephalography
NCT07809542Muscle Pain
Qilu Hospital of Shandong University
Observational
1,200
Jinan
2026-05-26
Not yet open
Deep Sedation vs. General Anesthesia for Pulsed Field Ablation in Atrial Fibrillation
NCT07621432Atrial Fibrillation (AF)
Second Affiliated Hospital of Nanchang University
Not applicable
80
Nanchang
2026-05-25
Not yet open
Management of Age-Related Auditory Decline and Early Warning of Its Co-occurring Dementia
NCT07608640Age-related Hearing Loss, Dementia
Chinese PLA General Hospital
Observational
3,000
Beijing
2026-05-25
Not yet open
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer
NCT07644533Electroacupuncture, Chemotherapy, Advanced Cancer, Peripheral Neuropathy
Affiliated Hospital of Qinghai University
Not applicable
264
Xining
2026-05-25
Recruiting
A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer
NCT07597629Advanced Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 2
36
Harbin
2026-05-25
Not yet open
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Early-stage Cancer
NCT07663396Electroacupuncture, Chemotherapy, Peripheral Neuropathy, Early Stage Cancer
Affiliated Hospital of Qinghai University
Not applicable
278
Xining
2026-05-25
Recruiting
Effects of Probiotics on the Gut-brain Axis in Children
NCT07459699Attention Deficit Hyperactivity Disorder (ADHD)
Probi AB
Not applicable
80
Shanghai
2026-05-25
Not yet open
AI vs. Physician for Anti-VEGF Decision-Making: An RCT
NCT07328776DME, Retinal Vein Occlusion (RVO), Neovascular (Wet) Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2026-05-25
Recruiting
Effect of Hot Spring Therapy on Central Fatigue Elimination During Altitude Training
NCT07615478Central Fatigue, Altitude Training, Cognitive Impairment, Hydrotherapy
Macao Polytechnic University
Not applicable
27
Macao
2026-05-25
Recruiting
Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorders
NCT07625748Autism Spectrum Disorder
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
16
Shanghai
2026-05-25
Recruiting
Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer
NCT07695259Elderly Females, HER2 + Breast Cancer, Neoadjuvant Therapy
Wen-Ming Cao
Phase 4
45
Hangzhou
2026-05-25
Recruiting
Effects of a 4-Week Altitude Training on Sport-Specific Performance, Body Composition, and Cardiac and Pulmonary Function in Adolescent Male Rowers
NCT07612956High-altitude Training Adaptations in Adolescent Male Rowers
Macao Polytechnic University
Not applicable
20
Macao
2026-05-25
Not yet open
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R08b in Parkinson's Disease Patients With GBA1 Mutations
NCT07414290Parkinson Disease (PD)
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 1/2
17
Changsha
2026-05-25
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases
NCT07614191Moderate to Severe Refractory Autoimmune Diseases
Vivacta Biotechnology (Shanghai) Co., Ltd.
Phase EARLY_PHASE1
22
Shanghai
2026-05-25
Active, closed
A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis
NCT07632976Antiphospholipid Syndrome (APS), Thrombosis
Shanghai Lanyi Therapeutics Co., Ltd.
Phase 1
12
Beijing
2026-05-25
Recruiting
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
NCT07617740REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-25
Not yet open
AI-GF-GNW on Prolonged Grief Reactions
NCT07589088Artificial Intelligence (AI), Prolonged Grief Symptoms, Depression - Major Depressive Disorder, Anxiety
Peking University
Not applicable
126
Beijing
2026-05-25
Not yet open
Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC
NCT07596134Unresectable Hepatocellular Carcinoma (HCC)
Zhejiang University
Not applicable
166
Kaifeng, Nanchang, Hangzhou, Yiwu
2026-05-25
Recruiting
Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia
NCT07591298Diagnosed With HoFH
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 2
18
Changsha
2026-05-24
Recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
NCT07583849COPD (Chronic Obstructive Pulmonary Disease)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
376
Beijing
2026-05-24
Recruiting
Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings
NCT07620223Hepatobiliary Surgery, Prophylactic Antibiotics
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
378
Nanjing
2026-05-24
Not yet open
Cohort Study of Postoperative Cognitive Dysfunction After Off-Pump Coronary Artery Bypass Grafting
NCT07643194Postoperative Cognitive Dysfunction (POCD)
Beijing Anzhen Hospital
Observational
600
Beijing
2026-05-24
Recruiting
Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
NCT07600983Streptococcus Pneumoniae Infection
CanSino Biologics Inc.
Phase 1/2
854
Shangqiu, Xuchang
2026-05-24
Recruiting
Observation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
NCT07722910Neovascular Glaucoma, Type 2 Diabetes
Qilu Hospital of Shandong University
Observational
98
Jinan
2026-05-23
Active, closed
Safety, Tolerability, Efficacy of EA0010 in OTOF Patients With CI
NCT07752888DFNB9, Cochlear Implantation
Shanghai EmayGene Technology Co., Ltd
Not applicable
1
Wuhan
2026-05-23
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856Colitis, Ulcerative
Janssen Research & Development, LLC
Phase 3
644
Beijing, Changzhou, Chongqing, Guangzhou, Huai'an, Ningbo, Shijiazhuang, Zhuzhou
2026-05-23
Recruiting
Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain
NCT07491146Pain After Abdominal Surgery
Yingyong Zhou,MD,PhD
Phase 2
200
Changsha, Chengdu
2026-05-23
Recruiting
Multicentric Database for KRAS Mutant Pancreatic Cancer
NCT07557849Pancreatic Cancer
Fudan University
Observational
1,000
Shanghai
2026-05-22
Recruiting
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
NCT07541534Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1
41
Chongqing, Jinan, Shanghai, Wuhan
2026-05-22
Recruiting
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma
NCT07167342Colorectal Adenoma, Probiotics
The Affiliated Hospital of Qingdao University
Phase 4
294
Qingdao, Weifang
2026-05-22
Recruiting
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
NCT07525206Colorectal Cancer
AbbVie
Phase 3
990
Beijing, Guangzhou, Nanning, Wuhan, Changchun, Shenyang, Yinchuan, Jinan
2026-05-22
Not yet open
A Single-Center Clinical Study to Evaluate the Efficacy and Safety of a Suture-Free Ophthalmic Hydrogel for Ocular Surface Tissue Adhesion
NCT07608367Cornea Disease
Suxia Li
Not applicable
20
Jinan
2026-05-22
Recruiting
Multicenter Validation of a Risk Prediction Model for MDRGNB Infection
NCT07603128Infection
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing, Ankang, Datong, Ganzhou, Hangzhou, Huaian, Nanning, Shanghai
2026-05-22
Recruiting
A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery
NCT07533786Pain After Surgery
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
200
Changsha, Chengdu
2026-05-22
Recruiting
Effect of Ischemic Preconditioning on Lower Extremity Motor Ability and Recovery in Basketball Players During Post-Match Recovery Period
NCT07604948Lower Extremity Explosive Power Deficit, Sports Recovery, Basketball Performance, Muscle Fatigue
Guangzhou Sport University
Not applicable
34
Guangzhou
2026-05-22
Recruiting
Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
NCT07595770Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
37
Guangzhou
2026-05-22
Recruiting
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS
NCT07607418AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome)
Ruijin Hospital
Phase 2
20
Shanghai
2026-05-22
Active, closed
Trial of HSK44459 Cream for the Management Plaque Psoriasis
NCT07623486Psoriasis
Haisco Pharmaceutical Group Co., Ltd.
Phase 1/2
180
Hangzhou
2026-05-22
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
NCT07577843Crohn Disease
Janssen Research & Development, LLC
Phase 3
460
Beijing, Changzhou, Chongqing, Guangzhou, Hangzhou, Huai'an, Ningbo, Zhuzhou
2026-05-22
Recruiting
A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC
NCT07567521Prostate Cancer
C Ray Therapeutics
Phase 1/2
90
Taiyuan, Shanghai
2026-05-22
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
NCT07638683Multiple Myeloma, AL Amyloidosis
Shanghai Zhongshan Hospital
Phase 2
30
Shanghai
2026-05-22
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
NCT07492641HR+/HER2- Breast Cancer
BeOne Medicines
Phase 3
1,056
Bengbu, Beijing, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning, Haikou
2026-05-22
Recruiting
Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
NCT07632118Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3
288
Tianjin
2026-05-22
Recruiting
Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes
NCT07674004Intracranial Aneurysms, Flow Diverter
Henan Provincial People's Hospital
Not applicable
196
Zhengzhou
2026-05-21
Recruiting
Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)
NCT07594314Acute Ischemic Stroke, Vessel Occlusion, Endovascular Thrombectomy, Anterior Circulation Brain Infarction
Xiang Luo
Phase 2/3
860
Wuhan
2026-05-21
Not yet open
A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease
NCT07555054Chronic Kidney Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 2
182
Guangzhou
2026-05-21
Rows per page Showing 2101–2200 of 19052
Previous 20 21 22 23 24 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=22

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.